Agency Information Collection Activities: Proposed Collection; Comment Request, 31842-31843 [07-2871]
Download as PDF
<![CDATA[
31842
Federal Register / Vol. 72, No. 110 / Friday, June 8, 2007 / Notices
drug products for use in the treatment
of arthritis, rheumatism, and related
diseases.
7. Cardiovascular and Renal Drugs
Advisory Committee
Reviews and evaluates available data
concerning the safety and effectiveness
of marketed and investigational human
drug products for use in the treatment
of cardiovascular and renal disorders.
8. Dermatologic and Ophthalmic Drugs
Advisory Committee
Reviews and evaluates available data
concerning the safety and effectiveness
of marketed and investigational human
drug products for use in the treatment
of dermatologic and ophthalmic
disorders.
9. Drug Safety and Risk Management
Advisory Committee
Advises the Commissioner of Food
and Drugs (the Commissioner) regarding
the scientific and medical evaluation of
all information gathered by the
Department of Health and Human
Services and the Department of Justice
with the regard to safety, efficacy, and
abuse potential, risk management, risk
communication, and quantitative
evaluation of spontaneous reports, and
recommends actions to be taken by FDA
with regard to marketing, investigation,
and control of such drugs or other
substances.
10. Endocrinologic and Metabolic Drugs
Advisory Committee
Reviews and evaluates available data
concerning the safety and effectiveness
of marketed and investigational human
drug products for use in the treatment
of endocrine and metabolic disorders.
11. Gastrointestinal Drugs Advisory
Committee
Reviews and evaluates available data
concerning the safety and effectiveness
of marketed and investigational human
drug products for use in the treatment
of gastrointestinal disorders.
pwalker on PROD1PC71 with NOTICES
12. Nonprescription Drugs Advisory
Committee
Reviews and evaluates available data
concerning the safety and effectiveness
of over-the-counter (nonprescription)
human drug products for use in the
treatment of a broad spectrum of human
symptoms and diseases.
13. Oncologic Drugs Advisory
Committee
Reviews and evaluates available data
concerning the safety and effectiveness
of marketed and investigational human
drug products for use in the treatment
of cancer.
VerDate Aug<31>2005
18:14 Jun 07, 2007
Jkt 211001
14. Peripheral and Central Nervous
System Drugs Advisory Committee
Reviews and evaluates available data
concerning the safety and effectiveness
of marketed and investigational human
drug products for use in the treatment
of neurologic diseases.
15. Psychopharmacologic Drugs
Advisory Committee
Reviews and evaluates available data
concerning the safety and effectiveness
of marketed and investigational human
drug products for use in the practice of
psychiatry and related fields.
16. Pulmonary-Allergy Drugs Advisory
Committee
Reviews and evaluates available data
concerning the safety and effectiveness
of marketed and investigational human
drug products for use in the treatment
of pulmonary disease and diseases with
allergic and/or immunologic
mechanisms.
II. Selection Procedure
Any industry organization interested
in participating in the selection of an
appropriate nonvoting member to
represent industry interests should send
a letter stating that interest to the FDA
contact (see FOR FURTHER INFORMATION
CONTACT) within 30 days of publication
of this document (see DATES). Within the
subsequent 30 days, FDA will send a
letter to each organization that has
expressed and interest, attaching a
complete list of all such organizations;
and a list of all nominees along with
their current resumes. The letter will
also state that it is the responsibility of
the interested organizations to confer
with one another and to select a
candidate, within 60 days after the
receipt of the FDA letter, to serve as the
nonvoting member to represent industry
interests for a particular committee. The
interested organizations are not bound
by the list of nominees in selecting a
candidate. However, if no individual is
selected within 60 days, the
Commissioner will select the nonvoting
member to represent industry interests.
III. Application Procedure
Individuals may self nominate and/or
an organization may nominate one or
more individuals to serve as a nonvoting
industry representative. A current
curriculum vitae and the name of the
committee of interest should be sent to
the FDA contact person (see FOR
FURTHER INFORMATION CONTACT) within
30 days (see DATES). FDA will forward
all nominations to the organizations
expressing interest in participating in
the selection process for that committee.
(Persons who nominate themselves as
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
nonvoting industry representatives will
not participate in the selection process.)
FDA has a special interest in ensuring
that women, minority groups,
individuals with physical disabilities,
and small businesses are adequately
represented on its advisory committees,
and therefore, encourages nominations
for appropriately qualified candidates
from these groups. Specifically, in this
document, nominations for nonvoting
representatives of industry interests are
encouraged from the drug
manufacturing industry.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: May 28, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. E7–11065 Filed 6–7–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Participant
Feedback on Training Under the
Cooperative Agreement for Mental
E:\FR\FM\08JNN1.SGM
08JNN1
31843
Federal Register / Vol. 72, No. 110 / Friday, June 8, 2007 / Notices
Health Care Provider Education in HIV/
AIDS Program (OMB No. 0930–0195)—
Extension
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Mental Health
Services (CMHS) intends to continue to
conduct a multi-site assessment for the
Mental Health Care Provider Education
in HIV/AIDS Program. These education
programs are designed to disseminate
knowledge of the psychological and
neuropsychiatric sequelae of HIV/AIDS
to both traditional (e.g., psychiatrists,
psychologists, nurses, primary care
physicians, medical students, and social
workers) and non-traditional (e.g.,
clergy, and alternative health care
workers) first-line providers of mental
health services, in particular to
providers in minority communities.
The multi-site assessment is designed
to assess the effectiveness of particular
training curricula, document the
integrity of training delivery formats,
and assess the effectiveness of the
various training delivery formats.
Analyses will assist CMHS in
documenting the numbers and types of
traditional and non-traditional mental
health providers accessing training; the
content, nature and types of training
participants receive; and the extent to
which trainees experience knowledge,
skill and attitude gains/changes as a
result of training attendance. The multisite data collection design uses a twotiered data collection and analytic
strategy to collect information on (1) the
organization and delivery of training,
and (2) the impact of training on
participant’s knowledge, skills and
abilities.
Information about the organization
and delivery of training will be
collected from trainers and staff, hence
there is no respondent burden. All
training participants will be asked to
complete a brief feedback form at the
end of the training session. CMHS
anticipates funding 10 education sites
for the Mental Health Care Provider
Education in HIV/AIDS Program. The
annual burden estimates for this activity
are shown below:
Responses
per respondent
Estimated number
of respondents
× 10 sites)
Session Report Form .............................................................................................
Participant Feedback Form (General Education) ..................................................
Neuropsychiatric Participant Feedback Form .......................................................
Non Physician Neuropsychiatric Participant Feedback Form ...............................
Adherence Participant Feedback Form .................................................................
Ethics Participant Feedback Form ........................................................................
1
1
1
1
1
1
60 × 10 = 600
500 × 10 = 5000
160 × 10 = 1600
240 × 10 = 2400
100 × 10 = 1000
200 × 10 = 2000
0.080
0.167
0.167
0.167
0.167
0.167
48
835
267
401
167
125
Total ................................................................................................................
....................
12,600
....................
1,843
Form
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 7–1044, One Choke Cherry Road,
Rockville, MD 20857 and e-mail her a
copy at summer.king@samhsa.hhs.gov.
Written comments should be received
within 60 days of this notice.
Dated: May 30, 2007.
Elaine Parry,
Acting Director, Office of Program Services.
[FR Doc. 07–2871 Filed 6–7–07; 8:45 am]
BILLING CODE 4162–20–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
pwalker on PROD1PC71 with NOTICES
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
VerDate Aug<31>2005
18:14 Jun 07, 2007
Jkt 211001
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: 2007 National Survey
of Mental Health Treatment Facilities
(NSMHTF) (OMB No. 0930–0119)—
Revision
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Mental Health
Services (CMHS) will conduct a 2007
NSMHTF. This national survey
represents a re-design of the biennial
Survey of Mental Health Organizations
(SMHO) last conducted in 2004 under
OMB No. 0930–0119. Instead of
surveying each mental health
organization as a whole, the 2007
NSMHTF will survey all of the mental
health treatment locations. These
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Hours per
response
Total hours
separate mental health service locations
are called facilities, in contrast to
mental health organizations, which may
include multiple facilities (service
locations). This survey will be (a) a 100
percent enumeration of all known
mental health treatment facilities
nationwide, (b) more consumer-oriented
in describing services available at each
facility location, and (c) patterned after
SAMHSA’s Office of Applied Studies
National Survey of Substance Abuse
Treatment Services (OMB No. 0930–
0106).
The 2007 NSMHTF will utilize one
questionnaire for all mental health
treatment facility types including
hospitals, residential treatment centers
and outpatient clinics. The information
collected will include intake telephone
numbers for services, types of services
offered and acceptable forms of
payment, emergency hotline numbers,
facility caseload, and facility bed
counts, if applicable. All treatment
facilities will be contacted by telephone
prior to the mailing to verify their
eligibility, and facility type.
The resulting database will be used to
provide both state and national
estimates of facility types and their
patient caseloads. Information from the
2007 survey will also be used to update
the National Mental Health Information
Center’s facility locator for consumers.
In addition, data derived from the
E:\FR\FM\08JNN1.SGM
08JNN1
]]>Agencies
[Federal Register Volume 72, Number 110 (Friday, June 8, 2007)]
[Notices]
[Pages 31842-31843]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2871]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Participant Feedback on Training Under the
Cooperative Agreement for Mental
[[Page 31843]]
Health Care Provider Education in HIV/AIDS Program (OMB No. 0930-
0195)--Extension
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) Center for Mental Health Services (CMHS) intends to continue
to conduct a multi-site assessment for the Mental Health Care Provider
Education in HIV/AIDS Program. These education programs are designed to
disseminate knowledge of the psychological and neuropsychiatric
sequelae of HIV/AIDS to both traditional (e.g., psychiatrists,
psychologists, nurses, primary care physicians, medical students, and
social workers) and non-traditional (e.g., clergy, and alternative
health care workers) first-line providers of mental health services, in
particular to providers in minority communities.
The multi-site assessment is designed to assess the effectiveness
of particular training curricula, document the integrity of training
delivery formats, and assess the effectiveness of the various training
delivery formats. Analyses will assist CMHS in documenting the numbers
and types of traditional and non-traditional mental health providers
accessing training; the content, nature and types of training
participants receive; and the extent to which trainees experience
knowledge, skill and attitude gains/changes as a result of training
attendance. The multi-site data collection design uses a two-tiered
data collection and analytic strategy to collect information on (1) the
organization and delivery of training, and (2) the impact of training
on participant's knowledge, skills and abilities.
Information about the organization and delivery of training will be
collected from trainers and staff, hence there is no respondent burden.
All training participants will be asked to complete a brief feedback
form at the end of the training session. CMHS anticipates funding 10
education sites for the Mental Health Care Provider Education in HIV/
AIDS Program. The annual burden estimates for this activity are shown
below:
----------------------------------------------------------------------------------------------------------------
Responses Estimated number
Form per of respondents x Hours per Total hours
respondent 10 sites) response
----------------------------------------------------------------------------------------------------------------
Session Report Form................................... 1 60 x 10 = 600 0.080 48
Participant Feedback Form (General Education)......... 1 500 x 10 = 5000 0.167 835
Neuropsychiatric Participant Feedback Form............ 1 160 x 10 = 1600 0.167 267
Non Physician Neuropsychiatric Participant Feedback 1 240 x 10 = 2400 0.167 401
Form.................................................
Adherence Participant Feedback Form................... 1 100 x 10 = 1000 0.167 167
Ethics Participant Feedback Form...................... 1 200 x 10 = 2000 0.167 125
------------------- ------------
Total............................................. ........... 12,600 ........... 1,843
----------------------------------------------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
Room 7-1044, One Choke Cherry Road, Rockville, MD 20857 and e-mail her
a copy at summer.king@samhsa.hhs.gov. Written comments should be
received within 60 days of this notice.
Dated: May 30, 2007.
Elaine Parry,
Acting Director, Office of Program Services.
[FR Doc. 07-2871 Filed 6-7-07; 8:45 am]
BILLING CODE 4162-20-M
